Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2GRIFOLS THERAPEUTICS LLC

02 1KI BIOPHARMA LLC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

HEPATITIS B IMMUNOGLOBULIN (HUMAN)

Brand Name : HYPERHEP B

Dosage Form : SOLUTION

Dosage Strength : 220UNIT/ML

Packaging :

Approval Date :

Application Number : 2520001

Regulatory Info : Schedule D

Registration Country : Canada

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

HEPATITIS B IMMUNOGLOBULIN (HUMAN)

Brand Name : HYPERHEP B

Dosage Form : SOLUTION

Dosage Strength : 110UNIT/0.5ML

Packaging :

Approval Date :

Application Number : 2520125

Regulatory Info : Schedule D

Registration Country : Canada

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

HEPATITIS B IMMUNOGLOBULIN (HUMAN)

Brand Name : HEPAGAM B

Dosage Form : SOLUTION

Dosage Strength : 312UNIT/ML

Packaging :

Approval Date :

Application Number : 2290979

Regulatory Info : Schedule D

Registration Country : Canada

blank